IHC News and Research

RSS
New study describes multi-method strategy to improve detection of PMS2 gene mutations in Lynch syndrome

New study describes multi-method strategy to improve detection of PMS2 gene mutations in Lynch syndrome

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics announces launch of new germline cancer predisposition testing services

Automated droplet-based surface sampling probe analyzes liver biopsy sample in 10 minutes

Automated droplet-based surface sampling probe analyzes liver biopsy sample in 10 minutes

OncoSec enrolls first patient in Phase II trial of ImmunoPulse IL-12 for treatment of HNSCC

OncoSec enrolls first patient in Phase II trial of ImmunoPulse IL-12 for treatment of HNSCC

VENTANA ALK (D5F3) CDx Assay receives FDA approval

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

Clinical utility of Caris Molecular Intelligence in five studies to be presented at ASCO 2015

Caris Molecular Intelligence allows comparisons between tumors sharing histological features

Caris Molecular Intelligence allows comparisons between tumors sharing histological features

Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways

Study findings underscore importance of PD-1/PD-L1 expression in oncogenic signaling pathways

Researchers identify key driver mutations in glioma samples that confirm tumor heterogeneity

Researchers identify key driver mutations in glioma samples that confirm tumor heterogeneity

Multiplatform biomarker analysis reveals new therapeutic options for squamous cell anal carcinomas

Multiplatform biomarker analysis reveals new therapeutic options for squamous cell anal carcinomas

Roche’s immunotherapy MPDL3280A better than chemotherapy in improving overall survival in NSCLC patients

Roche’s immunotherapy MPDL3280A better than chemotherapy in improving overall survival in NSCLC patients

Researchers report new label-free chemical imaging that provides similar information as molecular stains

Researchers report new label-free chemical imaging that provides similar information as molecular stains

Flagship Biosciences customizes assay development and tissue image analysis for advanced cell diagnostics RNAscope platform

Flagship Biosciences customizes assay development and tissue image analysis for advanced cell diagnostics RNAscope platform

Agena Bioscience releases LungFUSION Panel to identify gene fusions in NSCLC tumors

Agena Bioscience releases LungFUSION Panel to identify gene fusions in NSCLC tumors

Mesenchymal stem cell transplantation reduces opioid tolerance, opioid-induced pain

Mesenchymal stem cell transplantation reduces opioid tolerance, opioid-induced pain

Caris Life Sciences announces record-setting revenue for 2014

Caris Life Sciences announces record-setting revenue for 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Dartmouth scientists discover novel cancer resistance mechanism

Dartmouth scientists discover novel cancer resistance mechanism

UAB Research Probes Molecular Basis Of Rare Genetic Disorder

UAB Research Probes Molecular Basis Of Rare Genetic Disorder